Development of Other Products Clause Samples

The 'Development of Other Products' clause defines the rights of a party, typically a service provider or developer, to independently create, develop, or market products or services that are similar to or compete with those being developed under the current agreement. This clause clarifies that the party is not restricted from pursuing other business opportunities, even if they overlap in function or market with the contracted work, provided that confidential information is not misused. Its core function is to prevent the agreement from unduly limiting a party’s future business activities, thereby balancing innovation and competition with the protection of proprietary information.
Development of Other Products. As between the Parties, Forest shall have the sole right, at its sole cost and expense, to Develop Products other than the Memantine-Donepezil FDC Products for Commercialization in the Field in the Territory. The Development of such Products in the Field in the Territory shall [*]. All interactions with Regulatory Authorities in the Territory, including the FDA, with respect to any Product in the Field of Forest or its Affiliates other than Memantine-Donepezil FDC Products in the Field shall [*].
View SourceView Similar (4)
Development of Other Products. Nothing in this Agreement shall restrict the full right and entitlement of GSK and any Affiliate of GSK to work on its own or with or through any Third Party to research, optimize, develop, manufacture, file any Registration and/or commercialize any compounds and products other than the Compound, any Backup Compound or Products in the Field anywhere in the Territory without any financial obligation to Welichem.
View SourceView Similar (3)
Development of Other Products. (a) Bionutrics shall not have any rights with respect to any products other than the Products, as determined in accordance with the terms of Section 2.1. (b) The parties shall within thirty (30) days of the date of this Agreement execute a product license agreement for the development and commercialization of functional foods, medical foods, dietary supplements and similar non-pharmaceutical products based on Bionutrics’ compositions employing Nostrum Technology for product formulation, pursuant to which (i) Bionutrics and Nostrum shall act in good faith in the selection and approval of the products for development and commercialization (“Functional Nutrition Products”); (ii) Nostrum shall make reasonable efforts to develop these products; and (iii) Nostrum shall receive no royalties for this license or for the performance of its product development obligations thereunder. Subject to Nostrum’s retained rights as the sole owner of any Nostrum Technology used or transferred in connection with the product license agreement, Bionutrics shall have exclusive rights with respect to all such Functional Nutrition Products. (c) During the Three-Year Period, the parties shall negotiate in good faith one or more agreements for Formulations and/or Prestudies with respect to Target Active Agents jointly selected in good faith by the parties.
View Source

Related to Development of Other Products

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Manufacturing Rights (a) If QED fails to supply Product ordered by ViewRay in accordance with the terms of this Agreement regarding the quantity or quality of Products supplied to ViewRay, then QED shall within fifteen (15) Business Days of said failure present ViewRay with a plan to remedy the problem and shall use Commercially Reasonable Efforts to execute such plan and remedy the problem or QED shall secure an alternative source of supply within a reasonable time at no additional cost to ViewRay. Any such alternative source of supply shall be on terms substantially identical with the terms of this Agreement. If QED is unable to provide a plan to remedy the problem or secure an alternative source of supply within [***] after its initial failure to supply, then QED shall consult with ViewRay and the parties shall work together to remedy the problem. If QED is unable to remedy the supply problem after [***] (or longer as agreed in writing by the parties), commencing with the date upon which such failure to supply began, then ViewRay may at its option, and upon notice to QED, manufacture the Products itself or through a third party in accordance with the provisions of Section 3.10(b). [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. (b) If ViewRay notifies QED pursuant to Section 3.10(a), above, that ViewRay will manufacture the Products itself or through a third party, QED shall (i) deliver to ViewRay within thirty (30) days media embodying or disclosing all Program technology and Program proprietary or intellectual property rights necessary to enable ViewRay or its designee to manufacture Products conforming with the Specifications; and (ii) provide ViewRay or its designee, upon request, with reasonable assistance in establishing a back-up manufacturing line. ViewRay shall require any third party ViewRay designates to manufacture Products pursuant to this Section 3.10, to agree in writing to observe the terms of this Agreement relating to confidentiality and the manufacture of Products. Notwithstanding any provision of this Section 3.10 to the contrary, in no case shall QED be required to pay ViewRay in respect of any Products purchased by ViewRay from a third party operating a back-up manufacturing line established pursuant to this Section 3.10 or manufactured by ViewRay or its Affiliates pursuant to this Section 3.10.

  • Field The term “

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Marketing Rights Neither the Company nor any of its Subsidiaries have granted rights to license, market, or sell its products or services to any other Person and is not bound by any agreement that affects the Company’s (or any Subsidiary’s) exclusive right to develop, distribute, market or sell its products or services.